Measuring treatment outcomes in women with vulvodynia

Gary Ventolini, Gary Ventolini

Abstract

Vulvodynia or vulvar pain syndrome is a chronic, heterogeneous, and multifactorial gynecological condition with an estimated prevalence of 9 - 12%, broad and substantial effect on quality of life due to physical disabilities, psychological distress and sexual dysfunction. A rationale therapeutic approach for the treatment of vulvodynia is still under investigation. A review of treatment modalities proposed by most of the clinicians involved in managing these patients advocated initially utilizing non-invasive therapies and then to proceed gradually to more aggressive therapies. A multidisciplinary approach that includes behavioral science and neuroimaging is required and recommended. Additionally a team approach should be utilized to test and evaluate therapies including pelvic floor physiotheraphy, psychotherapy, microbiology and pharmacology. It is my hope that this review will assist in the understanding of vulvodynia and its measuring treatment outcomes and will provide a thrust in the right direction to once and for all clarify this complex multifactorial disorder affecting women.

Keywords: Treatment; Vulvodynia; Women.

References

    1. Petersen CD, Lundvall L, Kristensen E, Giraldi A. Vulvodynia. Definition, diagnosis and treatment. Acta Obstet Gynecol Scand. 2008;87(9):893–901.
    1. Arnold LD, Bachmann GA, Rosen R, Kelly S, Rhoads GG. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol. 2006;107(3):617–624.
    1. Hengge UR, Runnebaum IB. [Vulvodynia] Hautarzt. 2005;56(6):556–559.
    1. Reed BD, Haefner HK, Edwards L. A survey on diagnosis and treatment of vulvodynia among vulvodynia researchers and members of the International Society for the Study of Vulvovaginal Disease. J Reprod Med. 2008;53(12):921–929.
    1. Masheb RM, Kerns RD, Lozano C, Minkin MJ, Richman S. A randomized clinical trial for women with vulvodynia: Cognitive-behavioral therapy vs. supportive psychotherapy. Pain. 2009;141(1-2):31–40.
    1. Hartmann D, Strauhal MJ, Nelson CA. Treatment of women in the United States with localized, provoked vulvodynia: practice survey of women's health physical therapists. J Reprod Med. 2007;52(1):48–52.
    1. Murina F, Bernorio R, Palmiotto R. The use of amielle vaginal trainers as adjuvant in the treatment of vestibulodynia: an observational multicentric study. Medscape J Med. 2008;10(1):23.
    1. Backman H, Widenbrant M, Bohm-Starke N, Dahlof LG. Combined physical and psychosexual therapy for provoked vestibulodynia-an evaluation of a multidisciplinary treatment model. J Sex Res. 2008;45(4):378–385.
    1. McCormack WM, Spence MR. Evaluation of the surgical treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol. 1999;86(2):135–138.
    1. Bergeron S, Bouchard C, Fortier M, Binik YM, Khalife S. The surgical treatment of vulvar vestibulitis syndrome: a follow-up study. J Sex Marital Ther. 1997;23(4):317–325.
    1. Eva LJ, Narain S, Orakwue CO, Luesley DM. Is modified vestibulectomy for localized provoked vulvodynia an effective long-term treatment? A follow-up study. J Reprod Med. 2008;53(6):435–440.
    1. Leclair CM, Goetsch MF, Lee KK, Jensen JT. KTP-nd:YAG laser therapy for the treatment of vestibulodynia: a follow-up study. J Reprod Med. 2007;52(1):53–58.
    1. Reed BD, Haefner HK, Sen A, Gorenflo DW. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol. 2008;112(2 Pt 1):231–237.
    1. Bergeron S, Binik YM, Khalife S, Pagidas K. Vulvar vestibulitis syndrome: a critical review. Clin J Pain. 1997;13(1):27–42.
    1. Ehrstrom S, Kornfeld D, Rylander E, Bohm-Starke N. Chronic stress in women with localised provoked vulvodynia. J Psychosom Obstet Gynaecol. 2009;30(1):73–79.
    1. Reese JB. Results from an RCT testing a psychosocial treatment for vulvodynia: Methodological strengths and future directions. Pain. 2009;141(1-2):8–9.
    1. de Kruiff ME, ter Kuile MM, Weijenborg PT, van Lankveld JJ. Vaginismus and dyspareunia: is there a difference in clinical presentation? J Psychosom Obstet Gynaecol. 2000;21(3):149–155.
    1. Weijmar Schultz WC, Gianotten WL, van der Meijden WI, van de Wiel HB, Blindeman L, Chadha S, Drogendijk AC. Behavioral approach with or without surgical intervention to the vulvar vestibulitis syndrome: a prospective randomized and non-randomized study. J Psychosom Obstet Gynaecol. 1996;17(3):143–148.
    1. Bergeron S, Binik YM, Khalife S, Pagidas K, Glazer HI, Meana M, Amsel R. A randomized comparison of group cognitive--behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91(3):297–306.
    1. Desrochers G, Bergeron S, Khalife S, Dupuis MJ, Jodoin M. Fear avoidance and self-efficacy in relation to pain and sexual impairment in women with provoked vestibulodynia. Clin J Pain. 2009;25(6):520–527.
    1. Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Stodgell CJ. et al. The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness. Obstet Gynecol. 2009;113(4):825–832.
    1. Foster DC, Duguid Km. Abstract International Conference on Mechanism and Treatment of Neuropathic Pain. Rochester, New York: 1998. Open label study of oral desipramine and topical lidocaine for the treatment of vulvar vestibulitis.
    1. Sutton JT, Bachmann GA, Arnold LD, Rhoads GG, Rosen RC. Assessment of vulvodynia symptoms in a sample of U.S. women: a follow-up national incidence survey. J Womens Health (Larchmt) 2008;17(8):1285–1292.
    1. Murina F, Bianco V, Radici G, Felice R, Di Martino M, Nicolini U. Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomised controlled trial. BJOG. 2008;115(9):1165–1170.
    1. Hasenbring MI, Hallner D, Rusu AC. Fear-avoidance- and endurance-related responses to pain: development and validation of the Avoidance-Endurance Questionnaire (AEQ) Eur J Pain. 2009;13(6):620–628.
    1. Masheb RM, Lozano C, Richman S, Minkin MJ, Kerns RD. On the reliability and validity of physician ratings for vulvodynia and the discriminant validity of its subtypes. Pain Med. 2004;5(4):349–358.
    1. Riley JL 3rd, Zawacki TM, Robinson ME, Geisser ME. Empirical test of the factor structure of the West Haven-Yale Multidimensional Pain Inventory. Clin J Pain. 1999;15(1):24–30.
    1. Ruscheweyh R, Marziniak M, Stumpenhorst F, Reinholz J, Knecht S. Pain sensitivity can be assessed by self-rating: Development and validation of the Pain Sensitivity Questionnaire. Pain. 2009;146(1-2):65–74.
    1. Lukacz ES, Lawrence JM, Burchette RJ, Luber KM, Nager CW, Buckwalter JG. The use of Visual Analog Scale in urogynecologic research: a psychometric evaluation. Am J Obstet Gynecol. 2004;191(1):165–170.
    1. Abrams MP, Carleton RN, Asmundson GJ. An exploration of the psychometric properties of the PASS-20 with a nonclinical sample. J Pain. 2007;8(11):879–886.
    1. Goossens ME, Vlaeyen JW, Hidding A, Kole-Snijders A, Evers SM. Treatment expectancy affects the outcome of cognitive-behavioral interventions in chronic pain. Clin J Pain. 2005;21(1):18–26. discussion 69-72.
    1. Graziottin A, Brotto LA. Vulvar vestibulitis syndrome: a clinical approach. J Sex Marital Ther. 2004;30(3):125–139.
    1. Ponte M, Klemperer E, Sahay A, Chren MM. Effects of vulvodynia on quality of life. J Am Acad Dermatol. 2009;60(1):70–76.
    1. Westrom LV, Willen R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol. 1998;91(4):572–576.
    1. Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest. 1998;46(4):256–260.
    1. Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest. 2004;58(3):171–178.
    1. Halperin R, Zehavi S, Vaknin Z, Ben-Ami I, Pansky M, Schneider D. The major histopathologic characteristics in the vulvar vestibulitis syndrome. Gynecol Obstet Invest. 2005;59(2):75–79.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren